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Osteoarthritis (OA) of the knee is a common and 
disabling condition that may ultimately require 
surgical intervention. More than 100 000 total 
knee arthroplasties (TKA) are performed each 
year in the United Kingdom alone.1 This number 
is expected to increase year on year.2,3 Although 
TKA is generally effective at reducing pain and 
improving function in patients with end-stage OA, 
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Aims
Responsiveness to clinically important change is a key feature of any outcome measure. 
Throughout Europe, health-related quality of life following total knee arthroplasty 
(TKA) is routinely measured with EuroQol five-dimension (EQ-5D) questionnaires. The 
Patient-Reported Outcomes Measurement Information System 10-Question Short-Form 
(PROMIS-10 Global Health) score is a new general heath outcome tool which is thought to 
offer greater responsiveness. Our aim was to compare these two tools.
Patients and Methods
We accessed data from a prospective multicentre cohort study in the United Kingdom, 
which evaluated outcomes following TKA. The median age of the 721 patients was 
69.0 years (interquartile range, 63.3 to 74.6). There was an even division of sex, and 
approximately half were educated to secondary school level. The preoperative EQ-5D, 
PROMIS-10, and Oxford Knee Scores (OKS) were available and at three, six, and 12 months 
postoperatively. Internal responsiveness was assessed by standardized response mean 
(SRM) and effect size (Cohen’s d). External responsiveness was assessed by correlating 
change scores of the EQ-5D and PROMIS-10, with the minimal clinically important 
difference (MCID) of the OKS. Receiver operating characteristic (ROC) curves were used to 
assess the ability of change scores to discriminate between improved and non-improved 
patients. 
Results
All measures showed significant changes between the preoperative score and the various 
postoperative times (p < 0.001). Most improvement occurred during the first three months, 
with small but significant changes between three and six months, and no further change 
between six and 12 months postoperatively. SRM scores for EQ-5D, PROMIS-10, and OKS 
were large (> 0.8). ROC curves showed that both EQ-5D and PROMIS-10 were able to 
discriminate between patients who achieved the OKS MCID and those who did not  
(area under the curve (AUC) of 0.7 to 0.82).
Conclusion
The PROMIS-10 physical health tool showed greater responsiveness to change than the 
EQ-5D, most probably due to the additional questions on physical health parameters that 
are more susceptible to modification following TKA. The EQ-5D was, however, shown to 
be sensitive to clinically meaningful change following TKA, and provides the additional 
ability to calculate health economic utility scores. It is likely, therefore, that EQ-5D will 
continue to be the global health metric of choice in the United Kingdom.
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some patients report dissatisfaction with the outcome,4,5 with 
persistent physical impairment6 and limitations of activity.7-10 
It is thus vitally important to use appropriate metrics when 
reporting changes in symptoms and outcome prior to, and fol-
lowing, TKA. Patient-reported outcome measures (PROMs) 
are increasingly used to assess outcome. These questionnaires 
evaluate aspects of health, function, and quality of life from the 
perspective of the patient.11 General health or health-related 
quality-of-life (HRQoL) PROMs are typically used in combina-
tion with joint-specific or condition-specific scores in national 
data sets to generate the broadest picture of function, and to 
allow comparison with other conditions and forms of treatment.
In the United Kingdom, the current metric of choice for 
evaluating HRQoL is the EuroQol five-dimension score (EQ-
5D). This is commonly used as it allows the calculation of 
 quality-adjusted life years that are central to health-economic 
evaluation. The most used version is the EQ-5D-3L. Although 
its reliability and reproducibility have been well validated,12-14 
its responsiveness in patients who have undergone arthroplasty 
is somewhat limited.
The Patient-Reported Outcomes Measurement Information 
System 10 (PROMIS-10) Global Health survey is a ten-item 
questionnaire that assesses generic HRQoL compared with nor-
mal values for the general population.15 It was developed by the 
United States National Institute of Health to evaluate HRQoL, 
and is contrasted against United States normative scores. It 
measures five domains: physical function, fatigue, pain, emo-
tional distress, and social health on a five-point response matrix. 
The structure of the score should offer greater responsiveness to 
changes in general health.16
The international group, Outcome Measures in Rheumatol-
ogy (OMERACT), which defines core outcome measurement 
sets in rheumatic diseases, recognized responsiveness to clini-
cally important change as a key feature of any clinical outcome 
measure. Responsiveness is defined as the ability of an instru-
ment to measure change over time.17 Comparative evaluation 
of responsiveness of the PROMIS-10 Global Health score and 
EQ-5D has not been conducted in patients undergoing TKA. 
The aim of this study, therefore, was to compare the respon-
siveness of these HRQoL metrics and to compare them with a 
joint-specific score, to determine responsiveness.
Patients and Methods
Data from a prospective multicentre cohort study in the United 
Kingdom, investigating outcome following TKA (TRIO- 
POPULAR), were accessed. This study involved 721 patients 
undergoing primary TKA for OA from nine centres in the 
United Kingdom.18 This data set was chosen due to the nation-
ally representative sample and extent of data assessment time 
points. Patients were evaluated preoperatively, and at three, six, 
and 12 months following surgery. The median age of the 721 
patients was 69.0 years (interquartile range, 63.3 to 74.6). There 
was an even division of sex, and approximately half were edu-
cated to secondary school level (Table I). Ethical approval was 
granted by the office for Research Ethics Committees Northern 
Ireland (ORECNI) (13/NI/0101).
Table I. Baseline characteristics of the patients
Predictors All patients Patients lost to follow-up
Median age, yrs (IQR); n 69.0 (63.3 to 74.6); 721 69.1 (34.8 to 73.8); 17
Female sex, n (%) 379 (52.6) 15/17 (88.2)
Education, n (%) 719 17
Secondary school 356 (49.5) 11 (64.7)
Apprenticeship 81 (11.3) 1 (5.9)
Further education college 188 (26.2) 5 (29.4)
University degree 69 (9.6) 0 (0)
Further degree 25 (3.5) 0 (0)
Marital status, n (%) 719 17
Single 35 (4.9) 0 (0)
Married 485 (67.5) 11 (64.7)
Widowed 100 (13.9) 1 (5.9)
Divorced 67 (9.3) 4 (23.5)
Separated 8 (1.1) 0 (0)
Cohabiting 24 (3.4) 1 (5.9)
Clinical factors
Median duration of knee pain, yrs, (IQR); n 5.0 (2.0 to 10.0); 699 5.5 (2.5 to 11.5); 16
Median baseline Oxford Knee Score, score (IQR); n 21.0 (15.0 to 26.0), 709 24.0 (16.0 to 28.0); 14
Median EQ-5D score, (IQR); n 0.42 (0.25 to 0.42); 699 0.42 (0.25 to 0.46); 14
Median EQ-5D VAS score, (IQR); n 75.0 (62.0 to 85.0); 691 70.0 (65.0 to 86.0); 14
Median PROMIS Global Physical Health, score (IQR); n 37.4 (34.9 to 39.8); 706 37.4 (34.9 to 39.8); 15
Median PROMIS Global Mental Health, score (IQR); n 45.8 (41.4 to 48.3); 712 43.5 (41.1 to 49.6); 16
Comorbidities, n (%) 721
≤ 1 175 (24.3) 10 (58.8)
2 to 3 421 (58.4) 6 (35.3)
≥ 4 125 (17.3) 1 (5.9)
IQR, interquartile range; EQ-5D, EuroQol five-dimensions; VAS, visual analogue scale; PROMIS, Patient-Reported Out-
comes Measurement Information System
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The EQ-5D-3L consists of a descriptive system with five 
dimensions: mobility, self-care, usual activities, pain/discom-
fort, and anxiety/depression, with a three-option response for-
mat, and the EQ-5D visual analogue scale (VAS). Each EQ-5D 
profile was converted to a single summary index based on the 
evaluation of health states in the United Kingdom. A score of 1.0 
indicates best possible health, while negative values represent 
a health status worse than death. Separate to the EQ-5D pro-
file, the EQ-5D VAS is a quantitative measure of the patients’ 
self-assessment of their health on a visual analogue scale 
(0 being worst, 100 being best).
The PROMIS-10 Global Health also measures five domains: 
physical function, fatigue, pain, emotional distress, and social 
health. Items are rated on a five-point scale. It includes physical 
and mental health component scores that can be transformed to 
t score distributions with a mean of 50 and standard deviation 
of 10. A higher score indicates better health.
Joint-specific measures are designed to capture the influence 
of interventions on the joint in question. They tend to be more 
responsive to the effect of interventions than generic scores. 
The Oxford Knee Score (OKS) is a commonly used PROM that 
has been validated to measure the impact of pain and functional 
Fig. 1
Chart showing the mean outcome score by time following total knee 
arthroplasty. OKS, Oxford Knee Score; EQ-5D, EuroQol five-dimensions; 
VAS, visual analogue scale; PROMIS, Patient-Reported Outcomes Meas-
urement Information System.
disability in patients undergoing knee arthroplasty.19 The score 
consists of 12 items that evaluate pain and function, with five 
possible response options from 0 to 4. The summed total is 
reported (0 to 48), higher scores reflecting less pain and better 
function.
Statistical analysis. We evaluated responsiveness by perform-
ing paired Student’s t-tests of the change in scores (postopera-
tive score minus preoperative score). Percentage change was 
defined as the mean change scores divided by the baseline 
scores. Responsiveness was also assessed by the standardized 
response mean (SRM) and effect size using Cohen’s d.20 SRM 
was calculated by dividing the mean change score by the stand-
ard deviation of the change score, and effect size was calculated 
by dividing the mean change score by the standard deviation 
of baseline (preoperative) scores. An effect size of 0.2 is con-
sidered a small effect size, 0.5 is considered moderate, and 
> 0.8 is considered large.20 A bias-corrected bootstrap method 
with 2000 iterations was used to compare the differences in 
responsiveness estimates (SRM and effect size) between the 
measures.21,22 Bootstrapping is a resampling technique to draw 
numerous samples from the original sample with replacement.23 
Bias-corrected 95% confidence intervals for these differences 
were obtained.24
We determined external responsiveness by correlating the 
six-month change scores of the EQ-5D and PROMIS-10 with 
the minimal clinically important difference (MCID) of the 
OKS. It is widely accepted that the postoperative OKS score 
plateaus after six months.25 The MCID is the minimal change 
in a score that is perceived by the patient to be beneficial,26 
and is defined as more than five points for the OKS using the 
anchor method approach.27 Receiver operating characteristic 
(ROC) curves were used to assess the ability of change scores 
to discriminate between improved and non-improved patients, 
defined by the external criterion (dichotomized outcome of 
patients with an OKS MCID > 5). An area under the curve 
(AUC) value of 0.5 indicates a discriminatory value equiva-
lent to chance.
Correlations between the six-month postoperative change 
scores of EQ-5D, PROMIS-10, and OKS were tested using 
Pearson’s R correlation. All statistical analysis was undertaken 
in STATA version 14.0 (StataCorp, College Station, Texas, 
2015). Statistical significance was set at p < 0.05.
Results
Preoperatively, the median OKS score was 21.0, the median 
EQ5D quality of life score was 0.42, and the median physi-
cal health score was 37.4 (PROMIS Global Physical). The 
improved scores following surgery are shown in Figure 1. 
Most improvement in joint-specific function occurred in the 
early postoperative period and plateaued after six months. This 
change was captured to a lesser extent by the generic scores.
Patients who were lost to follow-up did not significantly dif-
fer in baseline age, sex, OKS, and health status (EQ-5D and 
PROMIS-10) (Table I), and no significant bias was assumed 
due to loss to follow-up.
Internal responsiveness. The OKS, EQ-5D, EQ-5D VAS, 
and PROMIS-10 physical health component scores all showed 
significant changes between the preoperative score and 
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postoperative times (p < 0.001; Table II). Most improvement 
occurred during the first three months in all patients, with small 
but significant changes between three and six months, and no 
further statistical change in any scores occurred between six 
and 12 months (Fig. 1 and Table II). Notably, the PROMIS-10 
mental health component showed no change at any time com-
pared with the preoperative values.
The OKS showed significantly greater SRM and effect sizes 
compared with the other scales. In accordance with Cohen’s 
criteria, the SRM scores for OKS, EQ-5D, EQ-5D VAS, and 
PROMIS-10 physical were large (SRM > 0.8), indicating large 
changes in these measures over time, and they remained respon-
sive at 12 months postoperatively. In contrast, the responsiveness 
of the VAS component of the EQ-5D and PROMIS-10 mental 
health was minimal to small (0.0 to 0.3), indicating little or no 
change over time (Table III). 
External responsiveness. Positive correlations were observed 
for all measures with the OKS (p < 0.001) (Table IV). The 
OKS correlated most with the PROMIS-10 Physical Health 
and the EQ-5D measures. The change in scores correlated only 
weakly with the change in OKS score. ROC curves showed that 
EQ-5D, EQ-5D VAS, and PROMIS-10 physical health were all 
able to discriminate between patients who achieved the OKS 
score MCID (> 5) and those who did not (AUC 0.7 to 0.82). 
PROMIS-10 mental health showed poorer discriminatory abil-
ity (AUC 0.59; Fig. 2).
Table II. Mean change score for each measure between the preoperative value and different times postoperatively
PROMs Mean 3 mths  
postoperative change  
score (95% CI); p-value*
Mean 6 mths  
postoperative change  
score (95% CI); p-value*
Mean 12 mths  
postoperative change  
score (95% CI); p-value*
Change in score  
between 3 and 6 mths 
(95% CI); p-value*
Change in score  
between 6 and 12 mths 
(95% CI); p-value*
OKS 12.68 (12.01 to 13.36);  
< 0.001
15.45 (14.79 to 16.12);  
< 0.001
16.27 (15.56 to 16.98);  
< 0.001
2.74 (2.32 to 3.16);  
< 0.001
0.81 (0.41 to 1.20);  
< 0.001
EQ-5D 0.12 (0.11 to 0.13);  
< 0.001
0.14 (0.13 to 0.16);  
< 0.001 
0.15 (0.14 to 0.17);  
< 0.001
0.03 (0.02 to 0.03);  
< 0.001
0.01 (-0.003 to 0.02);  
0.168
EQ-5D VAS 4.40 (2.99 to 5.82);  
< 0.001
5.28 (3.90 to 6.66);  
< 0.001
4.84 (3.39 to 6.29);  
< 0.001
1.03 (-0.08 to 2.14);  
0.068
-0.97 (-2.13 to 0.19);  
0.102
PROMIS  
Physical Health
4.97 (4.60 to 5.33);  
< 0.001
5.60 (5.25 to 5.95);  
< 0.001
5.57 (5.17 to 5.97);  
< 0.001
0.73 (0.44 to 1.03);  
< 0.001
-0.06 (-0.36 to 0.24);  
0.677
PROMIS  
Mental Health
0.03 (-0.34 to 0.40);  
0.875
0.18 (44.16 to 44.98);  
0.349
0.11 (-0.29 to 0.52);  
0.583
0.15 (-0.09 to 0.38);  
0.215
-0.10 (-0.33 to 0.14);  
0.421
*Paired-samples Student’s t-tests
PROMs, patient-reported outcome measures; CI, confidence interval; OKS, Oxford Knee Score; EQ-5D, EuroQol five-dimensions; VAS, visual ana-
logue scale; PROMIS, Patient-Reported Outcomes Measurement Information System
Table III. Responsiveness estimates of effect size and standardized response mean (SRM) of the Oxford Knee Score (OKS), EuroQol 5 dimensions 
(EQ-5D), and Patient-Reported Outcomes Measurement Information System (PROMIS)-10
PROMs Effect size 3 mths 
postoperative,  
Cohen d, (95% CI);  
p-value
Standardized  
response mean  
3 mths postoperative,  
(95% CI); p-value
Effect size 6 mths  
postoperative;  
Cohen d, (95% CI);  
p-value
Standardized  
response mean  
6 mths postoperative  
(95% CI); p-value
Effect size 12 mths  
postoperative,  
Cohen d, (95% CI);  
p-value
Standardized 
response mean 12 
mths postoperative 
(95% CI); p-value
OKS 1.63 (1.51 to 1.75);  
< 0.05
1.44 (1.33 to 1.55);  
< 0.05
1.95 (1.84 to 2.08); 
< 0.05
1.73 (1.61 to 1.85);  
< 0.05
1.97 (1.82 to 2.12);  
< 0.05
1.78 (1.64 to 1.92); 
< 0.05
EQ-5D 0.80 (0.71 to 0.88);  
< 0.05
0.72 (0.64 to 0.80);  
< 0.05
0.92 (0.83 to 1.01); 
< 0.05
0.83 (0.74 to 0.92);  
< 0.05
0.98 (0.88 to 1.08);  
< 0.05
0.87 (0.77 to 0.96); 
< 0.05
EQ-5D VAS 0.26 (0.17 to 0.34);  
< 0.05
0.24 (0.16 to 0.32);  
< 0.05
0.30 (0.22 to 0.38); 
< 0.05
0.29 (0.21 to 0.37);  
< 0.05
0.27 (0.19 to 0.35);  
< 0.05
0.26 (0.18 to 0.34) 
< 0.05
PROMIS  
Physical Health
1.16 (1.06 to 1.27);  
< 0.05
1.06 (0.96 to 1.15);  
< 0.05
1.30 (1.19 to 1.40); 
< 0.05
1.20 (1.11 to 1.32);  
< 0.05
1.22 (1.11 to 1.34);  
< 0.05
1.09 (0.98 to 1.19); 
< 0.05
PROMIS  
Mental Health 
0.01 (-0.07 to 0.08)* 0.01 (-0.07 to 0.08)* 0.04 (-0.03 to 0.12)* 0.04 (-0.03 to 0.12)* 0.02 (-0.06 to 0.10)* 0.02 (-0.06 to 0.10)*
*Not statistically significant (p > 0.05)
PROMs, patient-reported outcome measures; CI, confidence interval; VAS, visual analogue scale
Table IV. Correlations with change in Oxford Knee Score (OKS) at six months; external responsiveness
PROMs 1 PROMs 2 n Correlation (r) 95% CI p-value
Change in OKS Change in EQ-5D 649 0.51 0.45 to 0.57 < 0.001
Change in EQ-5D VAS 647 0.30 0.24 to 0.37 < 0.001
Change in PROMIS Physical Health 674 0.57 0.51 to 0.62 < 0.001
Change in PROMIS Mental Health 648 0.14 0.06 to 0.22 < 0.001
PROMs, patient-reported outcome measures; CI, confidence interval; EQ-5D; EuroQol 5 dimensions; VAS, visual analogue scale; PROMIS, Patient- 
Reported Outcomes Measurement Information System
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Discussion
We confirmed good responsiveness of the PROMIS-10 Global 
Health score when used for the evaluation of patients undergo-
ing TKA. As expected, the joint-specific tool (OKS) showed the 
greatest responsiveness to change following TKA. Both HRQoL 
measures were responsive to change following TKA. However, 
the PROMIS-10 physical health tool showed greater responsive-
ness than the EQ-5D, with the change in mean score, SRM, and 
effect size at all times, and the correlation to the joint-specific 
tool all greater in the PROMIS-10 physical health score com-
pared with the EQ-5D. This difference is most likely to be due 
to the additional questions and focus on parameters of physical 
health, which are more susceptible to modification following 
surgery to the knee than the evaluation offered by the EQ-5D. 
As expected, the mental health component of the PROMIS-10 
tool showed no difference over time following TKA. Most 
change in score in all other measures occurred during the first 
three months after surgery. There were small but statistically 
significant further changes in PROMIS-10, EQ-5D, and OKS 
scores between three and six months, while only the OKS 
recorded change between six and 12 months.
Although other studies have evaluated the responsiveness of 
the OKS and EQ-5D in arthroplasty,28,29 this is the first to eval-
uate and compare the responsiveness of the PROMIS-10 Global 
Health questionnaire in patients undergoing TKA. This is also 
the first analysis to record the ability of the health-related quality 
of life tools to detect a clinically meaningful change in the OKS.
Typically, the assessment of responsiveness can provide an 
indication of whether a measure can detect a statistically signifi-
cant change over time. Statistical significance does not, however, 
Fig. 2
Receiver operating characteristic (ROC) curves for EuroQol five-dimen-
sions (EQ-5D), EQ-5D visual analogue scale (VAS), and Patient-Reported 
Outcomes Measurement Information System (PROMIS) physical and 
mental health against the external criterion of a minimal clinically 
important difference (MCID) of a change in Oxford Knee Score (OKS) of 
greater than 5 points.
indicate whether this change is meaningful.30 Evaluating the com-
parative effect size and SRM of the health-related quality of life 
tools without an anchor of important change provides no informa-
tion about the ability of the tools in question to measure change in 
the underlying construct.31 We assessed this external responsive-
ness by evaluating the ability of the health-related quality-of-life 
measures to affect the accepted clinically meaningful change 
of five points on the OKS. Although the PROMIS-10 physical 
health component score correlated most with the OKS, ROC 
curve analysis showed that both PROMIS-10 physical health and 
EQ-5D tools were equally able to identify patients who achieved 
clinically meaningful joint-specific changes of function.
The primary strength of this study was the use of a large coun-
trywide multicentre study cohort with the collection of data at 
many times postoperatively, allowing a detailed evaluation of 
comparative responsiveness of the metrics throughout the recov-
ery period, and suggesting broad generalizability. Limitations 
include the predominance of early postoperative timepoint data 
collection, with no evaluation beyond one year postoperatively. 
One-year timeframes are typically reported in studies of the out-
come after arthroplasty, and no statistically significant or clin-
ically meaningful changes were apparent between six and 12 
months postoperatively, suggesting that the longitudinal data 
timepoints were sufficient to capture the period of recovery. 
Although the response rates declined during follow-up, loss to 
follow-up was minimal and unlikely to bias the estimates.
Understanding which PROMs are most responsive in clinical 
practice will ensure the collection of high-quality information 
that best reflects patient-centred health improvements and clin-
ical management. The PROMIS-10 Global Health tool offers 
superior responsiveness to change compared with the EQ5D in 
TKA, suggesting that it is a useful tool in this setting. A signifi-
cant advantage of the EQ-5D compared with the PROMIS tool, 
however, is the ability to calculate quality-adjusted life years, 
which can be used to perform health economic analysis. The 
tools offer a similar evaluation of the quality of life, and it is 
unlikely that both would be routinely asked of the same patients. 
Thus, the marginal gain in responsiveness of the PROMIS-10 
is unlikely to offer enough benefit to justify replacing the well- 
entrenched EQ-5D in United Kingdom arthroplasty studies.
Take home message
- Both the Patient-Reported Outcomes Measurement Infor-
mation System 10-Question Short-Form (PROMIS-10) and 
EuroQol five-dimension score (EQ-5D) tools are sensitive to 
clinically meaningful change following total knee  arthroplasty 
in cohorts in the United Kingdom, suggesting either is appropriate to 
evaluate health-related quality-of-life outcomes in clinical studies.
Twitter
Follow D. F. Hamilton @df_hamilton
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